Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs SBAC✓SelectedUSD · SBACMRNA vs SBAC performance historyLatest closeAs of-3.93%11/17
Stock and ETF performance explorer

MRNA vs SBAC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-17.7%
SBAC return
-45.7%
Excess return
+28.0%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioSBACExcessAlpha
1D-3.9%-6.5%+2.5%-1.7%
7D-17.6%-8.2%-9.3%-15.0%
30D-5.1%-6.1%+0.9%-3.2%
3M+220.8%-2.8%+223.7%+223.4%
6M+321.7%-10.8%+332.5%+333.5%
YTD+601.3%-7.4%+608.6%+601.7%
1Y+735.2%-8.5%+743.7%+740.4%
3Y+170.5%-20.3%+190.8%+182.1%
All-17.7%-45.7%+28.0%+6.6%

Cumulative growth

Daily Returns

Daily percentage return beside SBAC.

Daily Out/Under-Performance

Portfolio return minus SBAC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling